Pharma · Healthcare

Unit-level authentication for every dose.

DSCSA in the US. FMD in the EU. One verification layer.

Aeroz adds cryptographic unit identity and sub-60-second recall traceback on top of TraceLink, Antares Vision, and MediLedger — closing the operational gaps serialization leaves open. No rip-and-replace.

Fixed fee 14-day written report No commitment to proceed
DSCSA §582EU FMD 2011/62/EUEPCIS 2.0Form 3911Saleable returnsRecall traceback
The gap serialization leaves open

Serialization confirms the carton. It can't authenticate the unit.

Cloned barcodes

2D codes are data, not identity

A GS1 2D barcode can be photographed and reprinted. A cloned code scans as "valid" — the weakness EU FMD's design does not close on its own.

Saleable returns

Returns re-enter blind

Under DSCSA, returned product must be verified before resale. Carton-level data can't prove a specific unit is the original.

Recall speed

Traceback takes days

When a lot is recalled, reconstructing unit-level custody from disconnected systems is slow — and patients stay exposed in the meantime.

United States · DSCSA

Defensible by Nov 27, 2026.

Aeroz adds unit-level authentication, saleable-returns verification, and sub-60-second recall traceback on top of your serialization stack — mapped to Section 582 of the FD&C Act (21 U.S.C. § 360eee-1) and EPCIS 2.0.

Form 3911-ready6-year retentionVRS verificationATP credentialing
Recall traceback<60s
Verification scan<300ms
FDA notification window24h
Record retention6 yrs
Pilot to live4–8 wks
Directive2011/62/EU
In force9 Feb 2019
CarrierGS1 2D + crypto
DefeatsCloned barcode
European Union · FMD

Cryptographic proof the barcode can't give.

The Falsified Medicines Directive mandates a 2D barcode and tamper-evidence — but a 2D code can be cloned. Aeroz binds an AES-128 chip identity to each pack, so a counterfeit with a copied barcode fails the authentication check.

The unbreakable pair

The barcode says what. The chip proves it's real.

We don't fight the barcode — regulators require it. We anchor it. The GS1 2D barcode carries the regulated data; the Aeroz chip carries cryptographic identity. Clone the barcode and the chip check fails; remove the chip and the seal voids.

Attack2D barcode aloneNFC / UHF chipAeroz paired
Photograph & reprintClonedResistsFails counterfeit
Tamper / refillInvisibleSeal voidsSeal voids
Bulk dock verificationLine-of-sightUHF at distanceUHF at distance
Regulated data carrierGTIN, lot, expiryIdentity onlyBoth, bound
Offline durabilitySmudge / tearSealed ICRedundant
What you gain

Every scan becomes defensible data.

Authenticity events

Every verification — where, when, pass or fail — on the append-only log.

Custody chain

Each handoff (dock → ship → receive → dispense) as an EPCIS 2.0 event.

Seal state

Armed or breached, per unit, the moment it changes.

Cold-chain history

Temperature and shock excursions for sensitive biologics.

Diversion intelligence

First-scan geography exposes grey-market routes before they spread.

Regulator exports

Form 3911 and unit-level custody, generated from the same log in seconds.

Pharma compliance audit

Get audit-defensible — in 14 days.

A fixed-fee Aeroz audit produces a written gap analysis against DSCSA §582 or EU FMD, an EPCIS-readiness assessment of your stack, and a scoped remediation plan with cost and timeline.

Turnaround
14 days
Engagement
Fixed fee
Deliverable
Written report
Commitment
None to proceed
Fixed fee 14-day written report No commitment to proceed

What's included

  • §582 or FMD gap analysis against your current stack.
  • EPCIS 2.0 readiness across TraceLink, Antares, MediLedger.
  • Recall-traceback simulation to time-baseline your response.
  • Form 3911 mapping to FDA-ready submission format.
  • Pilot scope for one SKU or line.